Chet Kumar

Chet Kumar has an extensive work experience in the life sciences and healthcare industry. Chet is currently working at Verantos as the Vice President, Life Sciences, where they oversee the AI-powered deep phenotyping platform for research collaboration. Prior to Verantos, Chet worked at Santorin Sciences as an Advisor, providing consulting and advisory services in various areas related to life science and digital health companies. Chet also served as the Vice President, Life Science I Commercial at Verana Health from 2015 to 2020. Before that, Chet held leadership positions at DigiSight Technologies, Inc., VisionCare Ophthalmic Technologies (now Samsara Vision), and VisionCare Ophthalmic Technologies. On top of that, they have experience in marketing and reimbursement at VisionCare Ophthalmic Technologies, Inc., and served as a Marketing Manager at Oculex Pharmaceuticals. Chet'searly career included a role in EH&S at Incyte Pharmaceuticals.

Chet Kumar has obtained a Clinical Doctorate (D.P.T.) from the University of Southern California in the Department of Biokinesiology and Physical Therapy. Further information regarding the start and end years of this degree is not provided. Additionally, Chet has attended UC San Diego, but there is no information about the degree or field of study pursued there. Similarly, Chet has also attended Leland, but no details about the degree or field of study are available.